End-of-day quote
Korea S.E.
06:00:00 2024-07-04 pm EDT
|
5-day change
|
1st Jan Change
|
7,370
KRW
|
0.00%
|
|
-0.94%
|
+67.50%
|
Mar. 27 |
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. completed the acquisition of 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae.
|
CI
| Feb. 29 |
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. agreed to acquire 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae for KRW 40 billion.
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
51,829
|
60,810
|
80,830
|
105,432
|
61,683
|
218,609
|
Enterprise Value (EV)
1 |
36,316
|
55,271
|
76,056
|
103,834
|
45,434
|
81,795
|
P/E ratio
|
-5
x
|
-8.88
x
|
-720
x
|
-433
x
|
4.74
x
|
10.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.3
x
|
2.89
x
|
4.15
x
|
4.59
x
|
2.55
x
|
2.03
x
|
EV / Revenue
|
1.61
x
|
2.63
x
|
3.9
x
|
4.52
x
|
1.88
x
|
0.76
x
|
EV / EBITDA
|
-242
x
|
-10.6
x
|
-11.3
x
|
31.4
x
|
16.6
x
|
8.09
x
|
EV / FCF
|
-3.12
x
|
-91.8
x
|
-44.2
x
|
45.6
x
|
19.2
x
|
-2.48
x
|
FCF Yield
|
-32.1%
|
-1.09%
|
-2.26%
|
2.19%
|
5.21%
|
-40.2%
|
Price to Book
|
1.39
x
|
2.18
x
|
2.44
x
|
2.56
x
|
0.97
x
|
3.26
x
|
Nbr of stocks (in thousands)
|
37,421
|
37,421
|
37,421
|
40,629
|
47,448
|
49,684
|
Reference price
2 |
1,385
|
1,625
|
2,160
|
2,595
|
1,300
|
4,400
|
Announcement Date
|
3/21/19
|
3/18/20
|
3/16/21
|
3/18/22
|
3/21/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
22,544
|
21,049
|
19,495
|
22,982
|
24,183
|
107,892
|
EBITDA
1 |
-149.9
|
-5,206
|
-6,716
|
3,308
|
2,735
|
10,110
|
EBIT
1 |
-508.6
|
-6,169
|
-7,646
|
2,442
|
1,757
|
6,248
|
Operating Margin
|
-2.26%
|
-29.31%
|
-39.22%
|
10.63%
|
7.26%
|
5.79%
|
Earnings before Tax (EBT)
1 |
-9,765
|
-7,858
|
-1,881
|
-198.7
|
12,789
|
25,042
|
Net income
1 |
-9,824
|
-6,843
|
-107.4
|
-214.3
|
13,106
|
21,314
|
Net margin
|
-43.58%
|
-32.51%
|
-0.55%
|
-0.93%
|
54.19%
|
19.75%
|
EPS
2 |
-276.7
|
-183.0
|
-3.000
|
-6.000
|
274.0
|
429.9
|
Free Cash Flow
1 |
-11,646
|
-602.1
|
-1,721
|
2,278
|
2,369
|
-32,919
|
FCF margin
|
-51.66%
|
-2.86%
|
-8.83%
|
9.91%
|
9.79%
|
-30.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
68.86%
|
86.59%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
18.07%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/21/19
|
3/18/20
|
3/16/21
|
3/18/22
|
3/21/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
15,513
|
5,539
|
4,775
|
1,598
|
16,249
|
136,814
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-11,646
|
-602
|
-1,721
|
2,278
|
2,369
|
-32,919
|
ROE (net income / shareholders' equity)
|
-27.1%
|
-23.5%
|
-3.26%
|
-0.79%
|
24.3%
|
14%
|
ROA (Net income/ Total Assets)
|
-0.73%
|
-9.87%
|
-11.2%
|
2.95%
|
1.7%
|
1.99%
|
Assets
1 |
1,351,647
|
69,346
|
959
|
-7,272
|
770,898
|
1,073,369
|
Book Value Per Share
2 |
999.0
|
746.0
|
884.0
|
1,013
|
1,338
|
1,351
|
Cash Flow per Share
2 |
320.0
|
128.0
|
392.0
|
219.0
|
223.0
|
1,306
|
Capex
1 |
132
|
95.1
|
329
|
492
|
1,235
|
7,174
|
Capex / Sales
|
0.59%
|
0.45%
|
1.69%
|
2.14%
|
5.1%
|
6.65%
|
Announcement Date
|
3/21/19
|
3/18/20
|
3/16/21
|
3/18/22
|
3/21/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| +67.50% | 265M | | +24.34% | 3,475B | | +20.66% | 95.19B | | +17.89% | 88.04B | | +58.59% | 60.64B | | -19.11% | 50.89B | | +38.83% | 48.86B | | -21.25% | 48.76B | | +77.48% | 41.28B | | -5.72% | 26.56B |
Other Software
|